Medherant: Chair for the clinic
University of Warwick spin-out Medherant Ltd has appointed Ken Cunningham as its chair right in time for the companys move into the clinical development of its novel transdermal drug delivery patch technology. Cunningham is already Chairman of Abzena as well as Non-Executive Director of Verona Pharma plc.
Between 2006 and 2010, Cunningham was at SkyePharma plc, initially as Chief Operating Officer and subsequently as Chief Executive Officer. He holds a Medical Degree from St Mary’s, Imperial College London.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium